RED ABBEY VENTURE PARTNERS
Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately held and 9 publicly traded life sciences companies. Mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well as companies that are supporting these efforts with novel tools and products. Specifically, seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies.
RED ABBEY VENTURE PARTNERS
Founded:
2004-01-01
Status:
Active
Contact:
410-494-4230
Email Addresses:
[email protected]
Technology used in webpage:
SPF SSL By Default Domain Not Resolving Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Network Solutions DNS Barracuda Networks Network Solutions SSL
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-12-22 | Cohero Health | Red Abbey Venture Partners investment in Seed Round - Cohero Health | 2 M USD |
| 2014-10-08 | Atopix Therapeutics | Red Abbey Venture Partners investment in Series A - Atopix Therapeutics | 3.7 M USD |
| 2010-06-24 | Corridor Pharmaceuticals | Red Abbey Venture Partners investment in Series A - Corridor Pharmaceuticals | 13.01 M USD |
| 2009-11-24 | Oxagen | Red Abbey Venture Partners investment in Series C - Oxagen | 26.7 M USD |
| 2009-10-02 | Corridor Pharmaceuticals | Red Abbey Venture Partners investment in Series A - Corridor Pharmaceuticals | 10.75 M USD |
| 2008-10-23 | Corridor Pharmaceuticals | Red Abbey Venture Partners investment in Seed Round - Corridor Pharmaceuticals | 2.3 M USD |
| 2008-10-23 | MacroGenics | Red Abbey Venture Partners investment in Series D - MacroGenics | 25 M USD |
| 2008-04-21 | Stromedix | Red Abbey Venture Partners investment in Series B - Stromedix | 25 M USD |
| 2007-02-27 | Advanced BioHealing | Red Abbey Venture Partners investment in Series C - Advanced BioHealing | 25.5 M USD |
| 2006-08-23 | Kemia | Red Abbey Venture Partners investment in Series C - Kemia | 31 M USD |